Ind-Swift Labs.

{
  "main_header": {
    "sid": 393806,
    "name": "Ind-Swift Labs.",
    "stock_name": "Ind-Swift Labs.",
    "full_name": "Ind-Swift Laboratories Ltd",
    "name_url": "stocks-analysis/ind-swift-labs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "143.63",
    "chg": -0.57,
    "chgp": "-0.4%",
    "dir": -1,
    "prev_price": "144.20",
    "mcapval": "1,257.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532305,
    "symbol": "INDSWFTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE915B01019",
    "curr_date": "May 07",
    "curr_time": "",
    "bse_nse_vol": "1.88 lacs",
    "exc_status": "Active",
    "traded_date": "May 07, 2026",
    "traded_date_str": "2026 05 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ind-swift-labs-393806-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ind-swift-labs-393806-1&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Ind-Swift Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3965854",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_mojoScore_3965854.png",
        "date": "2026-04-28 08:22:35",
        "description": "Ind-Swift Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 27 April 2026. This change reflects a complex interplay of deteriorating financial fundamentals, cautious valuation metrics, and a shift in technical indicators, despite the company’s strong recent stock performance and positive quarterly results."
      },
      {
        "title": "Ind-Swift Laboratories Gains 3.98%: 4 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-gains-398-4-key-factors-driving-the-week-3962819",
        "imagepath": "",
        "date": "2026-04-25 17:10:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Apr:</strong> Downgrade to Sell amid mixed financial signals</p>\n                    <p><strong>22 Apr:</strong> Bullish momentum observed despite mixed technical indicators</p>\n                    <p><strong>23 Apr:</strong> Upgrade to Hold following technical and financial improvements</p>\n                    <p><strong>24 Apr:</strong> Technical momentum shifts to mildly bullish amid mixed signals</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.132.10</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><di..."
      },
      {
        "title": "Ind-Swift Laboratories Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3960053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_technicaldot_3960053.png",
        "date": "2026-04-24 08:00:56",
        "description": "Ind-Swift Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflected in a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade in daily price performance, the stock’s longer-term metrics suggest a cautiously optimistic outlook, prompting a reassessment of its technical stance from Sell to Hold."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Upgraded to Hold on Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-upgraded-to-hold-on-technical-and-financial-improvements-3958548",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_mojoScore_3958548.png",
        "date": "2026-04-23 08:11:00",
        "description": "Ind-Swift Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by a marked improvement in technical indicators and encouraging quarterly financial results. Despite lingering concerns over long-term fundamentals and profitability, the stock’s recent performance and technical outlook have prompted a reassessment of its market stance."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Sees Bullish Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-sees-bullish-momentum-amid-mixed-technical-signals-3956821",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_technicaldot_3956821.png",
        "date": "2026-04-22 08:01:29",
        "description": "Ind-Swift Laboratories Ltd has exhibited a notable shift in price momentum, with technical indicators signalling a transition from mildly bullish to bullish trends. Despite a mixed bag of signals from key metrics such as MACD, RSI, and moving averages, the stock’s recent performance and technical outlook suggest growing investor interest amid a volatile pharmaceutical sector backdrop."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Downgraded to Sell Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-downgraded-to-sell-amid-mixed-financial-signals-3953345",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_mojoScore_3953345.png",
        "date": "2026-04-20 08:10:26",
        "description": "Ind-Swift Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 17 Apr 2026. Despite recent positive quarterly results, the company’s long-term fundamentals and valuation concerns have weighed heavily on the decision, reflected in a MarketsMOJO Mojo Score of 44.0 and a Sell grade. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that triggered this rating change."
      },
      {
        "title": "Ind-Swift Laboratories Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-hold-3943347",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_mojoScore_3943347.png",
        "date": "2026-04-12 10:10:33",
        "description": "Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 April 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 156.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-new-52-week-high-at-rs1565-3939136",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_priceRelatedfactors_3939136.png",
        "date": "2026-04-09 09:40:37",
        "description": "With a remarkable 82.7% gain over the past year, Ind-Swift Laboratories Ltd has surged to a fresh 52-week high of Rs 156.5 on 9 Apr 2026, significantly outperforming the Sensex's modest 4.4% rise. This milestone underscores the stock's sustained momentum amid a broader market that is currently under pressure."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 154.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-new-52-week-high-at-rs1547-3938009",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndSwiftLaborat_priceRelatedfactors_3938009.png",
        "date": "2026-04-08 15:35:04",
        "description": "With a decisive surge to Rs 154.7 on 8 Apr 2026, Ind-Swift Laboratories Ltd has reached a fresh 52-week high, marking an impressive 82.96% gain over the past year. This milestone reflects a powerful alignment of technical indicators and sustained price momentum that has propelled the stock well ahead of the Sensex’s modest 4.49% rise during the same period."
      }
    ],
    "total": 188,
    "sid": "393806",
    "stock_news_url": "https://www.marketsmojo.com/news/ind-swift-laboratories-393806"
  },
  "announcements": [
    {
      "details": "Ind-Swift Laboratories Limited has informed the Exchange regarding 'Prior Intimation under Regulation 50 (1) and 60 (2) of SEBI (Listing Obligations and Disclosure requirements), Regulations, 2015 of Record Date and redemption/Payment of Interest Date'.",
      "source": "NSE",
      "caption": "Ind-Swift Laboratories Limited - Updates",
      "datetime": "09-Dec-2019"
    },
    {
      "details": " <table><tr><td>Ind-Swift Laboratories Limited has informed the Exchange regarding 'Prior Intimation under Regulations 50(1) and 60(2) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 of Record date and payment of Interest Date'. </td></tr></table>",
      "source": "NSE",
      "caption": "Updates",
      "datetime": "16-Sep-2019"
    },
    {
      "details": " <table><tr><td>Ind-Swift Laboratories Limited has informed the Exchange regarding 'Intimation regarding Publication of Notice of 24th AnnualGeneral Meeting of the Company in the Newspaper'. </td></tr></table>",
      "source": "NSE",
      "caption": "Updates",
      "datetime": "09-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ind-Swift Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 20 Sep 11",
          "dt": "2011-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Ind-Swift Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-04-28 08:22:35

Ind-Swift Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 27 April 2026. This change reflects a complex interplay of deteriorating financial fundamentals, cautious valuation metrics, and a shift in technical indicators, despite the company’s strong recent stock performance and positive quarterly results.

Read full news article

Ind-Swift Laboratories Gains 3.98%: 4 Key Factors Driving the Week

2026-04-25 17:10:30

Key Events This Week

20 Apr: Downgrade to Sell amid mixed financial signals

22 Apr: Bullish momentum observed despite mixed technical indicators

23 Apr: Upgrade to Hold following technical and financial improvements

24 Apr: Technical momentum shifts to mildly bullish amid mixed signals

Week Open

Rs.132.10

Week Close

Read full news article

Ind-Swift Laboratories Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals

2026-04-24 08:00:56

Ind-Swift Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflected in a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade in daily price performance, the stock’s longer-term metrics suggest a cautiously optimistic outlook, prompting a reassessment of its technical stance from Sell to Hold.

Read full news article

Ind-Swift Laboratories Ltd Upgraded to Hold on Technical and Financial Improvements

2026-04-23 08:11:00

Ind-Swift Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by a marked improvement in technical indicators and encouraging quarterly financial results. Despite lingering concerns over long-term fundamentals and profitability, the stock’s recent performance and technical outlook have prompted a reassessment of its market stance.

Read full news article

Ind-Swift Laboratories Ltd Sees Bullish Momentum Amid Mixed Technical Signals

2026-04-22 08:01:29

Ind-Swift Laboratories Ltd has exhibited a notable shift in price momentum, with technical indicators signalling a transition from mildly bullish to bullish trends. Despite a mixed bag of signals from key metrics such as MACD, RSI, and moving averages, the stock’s recent performance and technical outlook suggest growing investor interest amid a volatile pharmaceutical sector backdrop.

Read full news article

Ind-Swift Laboratories Ltd Downgraded to Sell Amid Mixed Financial Signals

2026-04-20 08:10:26

Ind-Swift Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 17 Apr 2026. Despite recent positive quarterly results, the company’s long-term fundamentals and valuation concerns have weighed heavily on the decision, reflected in a MarketsMOJO Mojo Score of 44.0 and a Sell grade. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that triggered this rating change.

Read full news article

Ind-Swift Laboratories Ltd is Rated Hold

2026-04-12 10:10:33

Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 156.5

2026-04-09 09:40:37

With a remarkable 82.7% gain over the past year, Ind-Swift Laboratories Ltd has surged to a fresh 52-week high of Rs 156.5 on 9 Apr 2026, significantly outperforming the Sensex's modest 4.4% rise. This milestone underscores the stock's sustained momentum amid a broader market that is currently under pressure.

Read full news article

Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 154.7

2026-04-08 15:35:04

With a decisive surge to Rs 154.7 on 8 Apr 2026, Ind-Swift Laboratories Ltd has reached a fresh 52-week high, marking an impressive 82.96% gain over the past year. This milestone reflects a powerful alignment of technical indicators and sustained price momentum that has propelled the stock well ahead of the Sensex’s modest 4.49% rise during the same period.

Read full news article

View All News